PWA
NMRA icon

Physician Wealth Advisors’s Neumora Therapeutics NMRA Stock Holding History

Physician Wealth Advisors’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.24K Hold
1,320
– – ﹤0.01% 1459
2026
Q1 		$2.57K Hold
1,320
– – ﹤0.01% 1242
2025
Q4 		$2.36K Hold
1,320
– – ﹤0.01% 1219
2025
Q3 		$2.4K Hold
1,320
– – ﹤0.01% 1140
2025
Q2 		$968 Buy
+1,320
New +$1K ﹤0.01% 1453

Other funds holding NMRA

WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
AH
Addis & Hill Wayne, Pennsylvania $181M AUM 21.74% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
LPT
Legacy Private Trust Neenah, Wisconsin $1.81B AUM 19.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Physician Wealth Advisors's NMRA Position: Q2 2026 in Review

Physician Wealth Advisors held its Neumora Therapeutics (NMRA) position steady in Q2 2026 at 1,320 shares worth $2.24K. The position accounts for ﹤0.01% of the portfolio, ranked #1459.

Physician Wealth Advisors first reported a position in NMRA in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.57K in Q1 2026. 14 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • Physician Wealth Advisors held 1,320 shares of Neumora Therapeutics worth $2.24K as of Q2 2026.
  • Physician Wealth Advisors left its Neumora Therapeutics share count unchanged in Q2 2026.
  • Neumora Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1459 holding.
  • Physician Wealth Advisors first reported a position in Neumora Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Physician Wealth Advisors's Neumora Therapeutics position peaked at $2.57K in Q1 2026.
  • 14 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.